Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Buy Ripple While It’s Under $1 As a Speculative Bet on Crypto’s Recovery

There are probably better cryptocurrencies than Ripple. However, if you want to make a speculative bet, under $1 is a smart place to start.

Top Grad Stocks 2021: An Apple Stock a Day Keeps the Losses Away

Colleges graduate thousands of students each year. As they enter the working world this is the stock to buy and hold forever.

Are Children the Solution to Novavax’s Vaccine Problem?

Canada’s vaccination rate is about to pass the U.S. That does not bode well for Novavax and NVAX stock. Are children the company’s savior?

Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing

Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1?   

Don’t Be Afraid of Bitcoin Regulation

Bitcoin lost some gains on May 20 after Treasury Department said it will crack down on cryptocurrency markets. That’s not a bad thing.

Naked Brand Group Stock Will Split Eventually, and Then You’ll Really Be Stuck

Nasdaq issued Naked Brand Group notice of minimum bid price non-compliance on April 29. Odds are good NAKD stock is about to reverse split. 

Litecoin Plummeted This Week, But Is It Worth Grabbing at a Low Price?

Like every cryptocurrency that dropped this week, proponents have a slew of arguments in its favor, but are those arguments legitimate?

5 Winning Stocks and 5 Losing Stocks to Watch Right Now

Every week the markets produce winners and losers. Here are 10 stocks to watch that outperformed or underperformed between May 12 and May 18.

Churchill Capital IV’s Merger With Lucid Motors Is Stalled Until Summer

Lucid Motors has had little to report in recent weeks. With few catalysts, CCIV stock had nowhere to go but down. Has anything changed? 

Bionano Genomics Moves Into Speculative Buy Territory

Bionano Genomics recently reported healthy Saphyr Systems sales in the first quarter. As a result, BNGO stock gained over 20%. Is it a buy?